跳至主要内容
临床试验/NCT02620124
NCT02620124已完成4 期

GnRH Anonist as Luteal Support in Frozen-thawed Embryo Transfer Cycles

Turku University Hospital0 个研究点目标入组 100 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
主要终点
Implantation rate

研究概览

简要总结

Back ground: A single dose of GnRH analogue in the luteal phase is reported to improve the outcome of IVF/ICSI treatments but the effect in FET cycles has not been reported.

Aim: To compare the results of frozen thawed embryo transfers with and without GnRHa analogue support Primary end point: IR, PR, on going PR Secondary end point: hCH, E2 and progesterone levels 14 days after thawing

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 20 - 45 year old women comig to frozen thawed embryo transfer

排除标准

  • The age of the woman over 42 years during the initial ICF/ICSI- treatment from which the embryos derive
  • Abnormal uterus
  • Known abnormality of karyotype of the woman or her partner
  • Severe male factor as an exclusive reason for subfertility
  • Allegy for triptorelin acetate

研究组 & 干预措施

Hormone replacement cycle, intervention

Experimental

Standard hormone replacement cycle with estrogen and progesteron and a single dose of 0.1 mg triptorelin when the age of the embryo was 6 days

干预措施: Hormone replacement cycle and triptorelin acetate 0.1 mg (Drug)

结局指标

主要结局

Implantation rate

时间窗: five weeks after the embryo transfer

Pregnancy rate

时间窗: five weeks after the embryo transfer

Ongoing pregnancy rate

时间窗: ten weeks after the embryo transfer

次要结局

  • hCG- level(14 days after thawing of the embryos)

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验

GnRH Agonist as Luteal Support in FET Cycles | 临床试验